| Literature DB >> 29724909 |
Lorenzo Caputi1, Jakob Franke1, Scott C Farrow1, Khoa Chung1, Richard M E Payne1, Trinh-Don Nguyen1, Thu-Thuy T Dang1, Inês Soares Teto Carqueijeiro2, Konstantinos Koudounas2, Thomas Dugé de Bernonville2, Belinda Ameyaw1, D Marc Jones1, Ivo Jose Curcino Vieira3, Vincent Courdavault4, Sarah E O'Connor5.
Abstract
Vinblastine, a potent anticancer drug, is produced by Catharanthus roseus (Madagascar periwinkle) in small quantities, and heterologous reconstitution of vinblastine biosynthesis could provide an additional source of this drug. However, the chemistry underlying vinblastine synthesis makes identification of the biosynthetic genes challenging. Here we identify the two missing enzymes necessary for vinblastine biosynthesis in this plant: an oxidase and a reductase that isomerize stemmadenine acetate into dihydroprecondylocarpine acetate, which is then deacetoxylated and cyclized to either catharanthine or tabersonine via two hydrolases characterized herein. The pathways show how plants create chemical diversity and also enable development of heterologous platforms for generation of stemmadenine-derived bioactive compounds.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29724909 DOI: 10.1126/science.aat4100
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 63.714